A Clinical Trial to Assess the Efficacy and Safety of Subjects With Dry Eye Disease

Clinical trial NCT06389214 · COMPLETED

Trial details

NCT number: NCT06389214
Sponsor: Aldeyra Therapeutics, Inc.
Status: COMPLETED
Phase: Phase 3
Study type: INTERVENTIONAL

Dry Eye Disease

Start date: 2024-04-09
Primary completion: 2024-06-11
Enrollment: 132

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.